The global near infrared imaging market Trends was valued at USD 1,184.3 Million in 2024 and is expected to reach USD 3,083.1 Million by 2033. The market is projected to grow at a CAGR of 11.2% during the forecast period from 2025 to 2033. This growth is driven primarily by the rising adoption of near-infrared imaging in cancer detection, advancements in camera technology, and increased use in pharmaceutical research.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
Near Infrared Imaging Market Key Takeaways
- Current Market Size: USD 1,184.3 Million in 2024
- CAGR: 11.2%
- Forecast Period: 2025-2033
- The increasing demand for non-invasive and real-time medical imaging techniques drives market growth.
- Rapid technological advancements in near-infrared camera miniaturization are expanding application possibilities.
- Growing integration of near-infrared imaging for non-destructive testing improves manufacturing quality control.
- Government initiatives and regulations globally support adoption in healthcare, agriculture, and industrial sectors.
- North America accounts for the largest share of the market due to robust healthcare infrastructure and research activities.
Sample Request Link: https://www.imarcgroup.com/near-infrared-imaging-market/requestsample
Market Growth Factors
The global near infrared imaging market is driven by the increasing demand for non-intrusive, real-time medical imaging such as cancer screening and treatment monitoring and developments in near-infrared camera technologies.
Furthermore, the technique's adoption in pharmaceutical research can have positive effects on drug development and the growth of the market over the next few years.
Rapid development and miniaturization of near-infrared cameras is a second main driver. Smaller, lighter weight, lower-power, and higher-performance cameras will allow hand-held devices to be used for medical diagnostics, agricultural monitoring, and industrial inspection. The portability and low price associated with miniaturized cameras has led to their common adoption for use throughout industry.
Different industries' demand for non-destructive testing (NDT) and quality control drives market growth. Near-infrared imaging is used by manufacturers throughout industries, such as automotive, aerospace, and pharmaceuticals for detecting defects, cracks, and other variations without damaging the products. Also, having high-resolution real-time images available reduces product recalls, improves production quality, and increases inspection efficiency, which further propels the market to grow.
There are also various government programs and regulations to support the market. These programs promote the use of near-infrared imaging in the healthcare sector, agriculture, and manufacturing. Regulatory bodies provide doctors and agricultural organizations with financial incentives, and products must meet certain quality benchmarks. Regulatory policies in the industry, such as quality and environmental standards, have created a conducive market.
Market Segmentation
By Product:
- Devices
- Near-infrared Fluorescence Imaging Systems
- Near-infrared Fluorescence and Bioluminescence Imaging Systems
- Reagents
- Indocyanine Green (ICG)
- Other Reagents
Devices dominate the market, including near-infrared imaging cameras and systems that provide improved image quality, resolution, and sensitivity for various applications, driven by technological advancements and demand across healthcare and industrial fields. Reagents such as fluorescent dyes enhance visualization and detection capabilities, gaining adoption in research and medical diagnostics.
By Application:
- Preclinical Imaging
- Cancer Surgeries
- Brain Cancer/Tumor Surgeries
- Other Cancer Surgeries
- GI (Gastrointestinal) Surgeries
- Colorectal Surgeries
- Other GI (Gastrointestinal) Surgeries
- Cardiovascular Surgeries
- Plastic/Reconstructive Surgeries
- Others
Cancer surgeries hold the largest market share, utilizing near-infrared imaging for precise tumor margin visualization and lymph node identification, which improves surgical accuracy and outcomes. Preclinical imaging and surgeries like gastrointestinal and cardiovascular also benefit for tissue viability assessment and surgical guidance.
By End User:
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Research Laboratories and Academic Institutes
- Others
Hospitals and clinics lead end-user segments, relying on near-infrared imaging for diagnosis, treatment planning, and monitoring. Pharmaceutical and biotechnology companies utilize the technology in drug discovery and in vivo imaging, while research institutions apply it for studying biological processes.
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Regional Insights
North America dominates the near infrared imaging market, benefiting from robust healthcare infrastructure, extensive research and development, and a strong pharmaceutical sector. The region’s focus on technological advancements and well-established medical facilities drive the largest market share globally. Europe follows with strong healthcare systems and demand for personalized medicine, supporting significant market growth.
Key Players
- Carl Zeiss AG
- Fluoptics (Getinge AB)
- Karl Storz SE & Co. KG
- Leica Microsystems GmbH (Danaher Corporation)
- LI-COR, Inc.
- Medtronic plc
- Shimadzu Corporation
- Stryker Corporation
Customization Note:
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
